QUOTE AND NEWS
SeekingAlpha  Aug 14  Comment 
By Jim Bowie: Typical antibiotic regimes for treating Acute Bacterial Skin and Skin Structure Infections ("ABSSSI") have run about 7 - 14 days and often include twice daily infusions to treat serious infections. These long-winded treatments...
DailyFinance  Aug 7  Comment 
The Medicines Company (NASDAQ:MDCO) today announced that in collaboration with Alnylam Pharmaceuticals (NASDAQ:ALNY) it will be hosting the “ALN-PCSsc for the treatment of Hypercholesterolemia” RNAi Roundtable webcast on...
FierceBiotech  Aug 7  Comment 
More than 5 years after The Medicines Company bagged Targanta and its troubled antibiotic oritavancin for the bargain basement rate of $42 million plus potential bonus payments, the biotech has finally nailed down an elusive FDA approval of the...
StreetInsider.com  Aug 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Medicines+%28MDCO%29+Stock+Gains+on+FDA+Approval+of+ORBACTIV/9730592.html for the full story.
newratings.com  Aug 7  Comment 
WASHINGTON (dpa-AFX) - BioDelivery Sciences International Inc. (BDSI) has completed a pre-specified interim analysis of the ongoing initial pivotal phase III trial for Clonidine Topical Gel for the treatment of painful diabetic neuropathy, and...
Market Intelligence Center  Aug 5  Comment 
For a hedged play on Medicines Company (MDCO), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Jan. '15 $23.00 covered call for a net debit in the $21.10 area. That is also the break-even stock price for the covered...
SeekingAlpha  Jul 23  Comment 
The Medicines Company (NASDAQ:MDCO) Q2 2014 Results Earnings Conference Call July 23, 2014, 08:30 AM ET Executives Neera Dahiya Ravindran - IR Clive Meanwell - CEO Glenn Sblendorio - President and CFO Cees Heiman - CIO and EVP ...
Motley Fool  Jul 18  Comment 
MiMedx, The Medicines Company, and Pacira Therapeutics should all see huge leaps in their earnings going forward. Here's what you need to know.
Market Intelligence Center  Jul 15  Comment 
After Monday’s trading in Medicines Company (MDCO) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 6.56% or 25.19% (for comparison purposes only), while providing 10.29%...
Forbes  Jul 7  Comment 
Although there is broad consensus in the medical community that immediate stenting (primary PCI) is the best treatment for heart attack patients when it can be delivered promptly, there is no agreement about the best accompanying drug regimen,...




RELATED WIKI ARTICLES
 

Based in Parsippany, NJ, The Medicines Company (MDCO) is engaged in acquiring, developing, and marketing specialty pharmaceutical primarily for cardiovascular indications. Its leading product, Angiomax (bivalirudin), which was acquired from Biogen Idec, Inc. in 1996, is used as an anticoagulant in patients undergoing coronary angioplasty. The company's other late-stage products include Clevidipine and Cangrelor, both acquired from AstraZeneca several years ago. Clevidipine is an intravenous drug (calcium channel blocker) intended for the short-term control of blood pressure in patients undergoing cardiac surgery. Cangrelor is an intravenous anticoagulant, having potential uses in coronary angioplasty and cardiac surgery. The company sells its products through its own sales force and distributors. In 2006, sales of Angiomax helped generate $214.0 million revenue.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki